Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Other Current Liabilities Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Other Current Liabilities
kr4.3B
CAGR 3-Years
49%
CAGR 5-Years
54%
CAGR 10-Years
18%
Zealand Pharma A/S
CSE:ZEAL
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Other Current Liabilities
€298.3m
CAGR 3-Years
150%
CAGR 5-Years
54%
CAGR 10-Years
37%
B
Bavarian Nordic A/S
CSE:BAVA
Other Current Liabilities
kr2B
CAGR 3-Years
193%
CAGR 5-Years
165%
CAGR 10-Years
30%
F
Fluoguide AS
STO:FLUO
Other Current Liabilities
kr2m
CAGR 3-Years
-41%
CAGR 5-Years
104%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Current Liabilities
kr80k
CAGR 3-Years
-84%
CAGR 5-Years
-60%
CAGR 10-Years
-37%

See Also

What is Genmab A/S's Other Current Liabilities?
Other Current Liabilities
4.3B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Other Current Liabilities amounts to 4.3B DKK.

What is Genmab A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
18%

Over the last year, the Other Current Liabilities growth was 123%. The average annual Other Current Liabilities growth rates for Genmab A/S have been 49% over the past three years , 54% over the past five years , and 18% over the past ten years .

Back to Top